Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03904134 · ClinicalTrials.gov registry record · NA
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
A NA study, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- NA
- Development phase
- 1,753
- Enrollment target
NCT03904134 is a NA study that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 1,753 participants.
The verdict
NCT03904134, a NA study, has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,753 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will result in better survival for allogeneic transplant recipients within 2 years after study enrollment.
Interventions
- OTHER Donor Search Prognosis Score
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,753 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2025-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03904134
The ClinicalTrials.gov registry entry for NCT03904134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,753 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donor Search Prognosis Score is the first listed.
NCT03904134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03904134 about?
NCT03904134 is a clinical study titled "Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)". The purpose of this study is to determine if a search strategy of searching for an HLA-matched unrelated donor for allogeneic transplantation if possible then an alternative donor if an HLA-matched unrelated donor is not available versus proceeding directly to an alternative donor transplant will re...
What is the current status of trial NCT03904134?
This trial is currently completed. It is a NA study. The enrollment target is 1,753 participants. The study started on 2019-06-14. Estimated completion is 2025-01-06.
What interventions are being tested in trial NCT03904134?
The interventions under investigation include: Donor Search Prognosis Score (OTHER).
Who is sponsoring clinical trial NCT03904134?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.